Clinical features of LRP4/agrin‐antibody–positive myasthenia gravis: A multicenter study
Introduction Our aim in this study was to identify the prevalence and clinical characteristics of
LRP4/agrin‐antibody–positive double‐seronegative myasthenia gravis (DNMG). Methods …
LRP4/agrin‐antibody–positive double‐seronegative myasthenia gravis (DNMG). Methods …
Clinical features of LRP4/agrin-antibody–positive myasthenia gravis: A multicenter study
MH Rivner, BM Quarles, JX Pan, Z Yu… - Muscle and …, 2020 - scholars.uthscsa.edu
Introduction: Our aim in this study was to identify the prevalence and clinical characteristics
of LRP4/agrin-antibody–positive double-seronegative myasthenia gravis (DNMG). Methods …
of LRP4/agrin-antibody–positive double-seronegative myasthenia gravis (DNMG). Methods …
Clinical features of LRP4/agrin-antibody–positive myasthenia gravis: A multicenter study
MH Rivner, BM Quarles, JX Pan, Z Yu, JF Howard… - Muscle and …, 2020 - pure.psu.edu
Introduction: Our aim in this study was to identify the prevalence and clinical characteristics
of LRP4/agrin-antibody–positive double-seronegative myasthenia gravis (DNMG). Methods …
of LRP4/agrin-antibody–positive double-seronegative myasthenia gravis (DNMG). Methods …
Clinical features of LRP4/agrin‐antibody–positive myasthenia gravis: A multicenter study
MH Rivner, BM Quarles, JX Pan, Z Yu, JF Howard… - Muscle & Nerve, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Introduction</jats: title>< jats: p>
Our aim in this study was to identify the prevalence and clinical characteristics of LRP4/agrin …
Our aim in this study was to identify the prevalence and clinical characteristics of LRP4/agrin …
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study.
MH Rivner, BM Quarles, JX Pan, Z Yu… - Muscle & …, 2020 - europepmc.org
Methods DNMG patients at 16 sites in the United States were tested for LRP4 and agrin
antibodies, and the clinical data were collected. Results Of 181 DNMG patients, 27 (14.9%) …
antibodies, and the clinical data were collected. Results Of 181 DNMG patients, 27 (14.9%) …
Clinical features of LRP4/agrin-antibody–positive myasthenia gravis: A multicenter study
MH Rivner, BM Quarles, JX Pan, Z Yu… - Muscle and …, 2020 - researchwithrutgers.com
Introduction: Our aim in this study was to identify the prevalence and clinical characteristics
of LRP4/agrin-antibody–positive double-seronegative myasthenia gravis (DNMG). Methods …
of LRP4/agrin-antibody–positive double-seronegative myasthenia gravis (DNMG). Methods …
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study
MH Rivner, BM Quarles, JX Pan, Z Yu… - Muscle & …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction Our aim in this study was to identify the prevalence and clinical characteristics of
LRP4/agrin-antibody-positive double-seronegative myasthenia gravis (DNMG). Methods …
LRP4/agrin-antibody-positive double-seronegative myasthenia gravis (DNMG). Methods …
[HTML][HTML] Clinical features of LRP4/agrin‐antibody–positive myasthenia gravis: A multicenter study
MH Rivner, BM Quarles, JX Pan, Z Yu… - Muscle & …, 2020 - ncbi.nlm.nih.gov
Methods DNMG patients at 16 sites in the United States were tested for LRP4 and agrin
antibodies, and the clinical data were collected. Results Of 181 DNMG patients, 27 (14.9%) …
antibodies, and the clinical data were collected. Results Of 181 DNMG patients, 27 (14.9%) …
Clinical features of LRP4/agrin-antibody–positive myasthenia gravis: A multicenter study
MH Rivner, BM Quarles, JX Pan, Z Yu… - Muscle and …, 2020 - augusta.elsevierpure.com
Introduction: Our aim in this study was to identify the prevalence and clinical characteristics
of LRP4/agrin-antibody–positive double-seronegative myasthenia gravis (DNMG). Methods …
of LRP4/agrin-antibody–positive double-seronegative myasthenia gravis (DNMG). Methods …
Clinical features ofLRP4/agrin-antibody-positive myasthenia gravis: A multicenter study
MH Rivner, BM Quarles, JX Pan, Z Yu, JF Howard… - Muscle & nerve, 2020 - iro.uiowa.edu
Introduction Our aim in this study was to identify the prevalence and clinical characteristics of
LRP4/agrin-antibody-positive double-seronegative myasthenia gravis (DNMG). Methods …
LRP4/agrin-antibody-positive double-seronegative myasthenia gravis (DNMG). Methods …